Biogen Idec Inc. (NDAQ:BIIB) President and CEO James Mullen pulled in $12.2 million in 2006 according to a proxy statement filed with the SEC. The pay package consisted of $1.08 million in salary, $2 million in cash awards, $5.78 million in restricted stock awards, and $3.21 million in option grants. The company's stock price between now and 2006 has moved up only 3.78%; however, the company did recently report strong earnings on MS and Cancer drugs that were inline with analyst estimates.